Bristol Myers Squibb (NYSE: BMY) strengthens Camzyos growth case with positive adolescent SCOUT-HCM data
Read More Pharma Industry News Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire… bypharmanewsdailyNovember 25, 2019
